Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial-Reference-Cited by-同舟云学术

Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

Published:2006-09 Issue:3 Volume:152 Page:500-508
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Reed Shelby D.,McMurray John J.V.,Velazquez Eric J.,Schulman Kevin A.,Califf Robert M.,Kober Lars,Maggioni Aldo P.,Van de Werf Frans,White Harvey D.,Diaz Rafael,Mareev Viatcheslav,Murin Jan

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE Investigators;Rouleau;N Engl J Med,1993

2. Differences in the treatment of myocardial infarction in the United States and Canada. A comparison of two university hospitals;Pilote;Arch Intern Med,1994

3. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation

4. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial;Pilote;Med Care,1995

5. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries;Van de Werf;JAMA,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographic differences in patients with acute myocardial infarction in the PARADISE‐MI trial;European Journal of Heart Failure;2023-04-28

2. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality;International Journal of Cardiology;2017-10

3. Association of beta‐blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched‐cohort analysis from the High‐Risk Myocardial Infarction Database Initiative;European Journal of Heart Failure;2016-10-24

4. PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES;Rational Pharmacotherapy in Cardiology;2011-01-01

5. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial;American Heart Journal;2010-06